Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Sales (2018 - 2025)

Historic Return on Sales for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to 3.73%.

  • Autolus Therapeutics' Return on Sales rose 230200.0% to 3.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.4%, marking a year-over-year increase of 223600.0%. This contributed to the annual value of 21.8% for FY2024, which is 1009200.0% up from last year.
  • Latest data reveals that Autolus Therapeutics reported Return on Sales of 3.73% as of Q3 2025, which was up 230200.0% from 2.29% recorded in Q2 2025.
  • Autolus Therapeutics' Return on Sales' 5-year high stood at 2.29% during Q2 2025, with a 5-year trough of 951.93% in Q4 2024.
  • For the 5-year period, Autolus Therapeutics' Return on Sales averaged around 127.7%, with its median value being 30.81% (2023).
  • Per our database at Business Quant, Autolus Therapeutics' Return on Sales surged by 1924500bps in 2023 and then plummeted by -8292100bps in 2024.
  • Over the past 5 years, Autolus Therapeutics' Return on Sales (Quarter) stood at 189.86% in 2021, then skyrocketed by 96bps to 7.37% in 2022, then plummeted by -1564bps to 122.72% in 2023, then plummeted by -676bps to 951.93% in 2024, then surged by 100bps to 3.73% in 2025.
  • Its Return on Sales stands at 3.73% for Q3 2025, versus 2.29% for Q2 2025 and 7.81% for Q1 2025.